{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:29:42Z","timestamp":1790303382318,"version":"4.1.0"},"reference-count":34,"publisher":"Society of Nuclear Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,3,13]]},"published-print":{"date-parts":[[2026,7]]},"DOI":"10.2967\/jnumed.125.271565","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:20:13Z","timestamp":1775744413000},"page":"1164-1169","source":"Crossref","is-referenced-by-count":2,"title":["A Novel CD147-Targeting Nanobody for Immuno-PET Imaging of Liver Cancer"],"prefix":"10.2967","volume":"67","author":[{"given":"Divya M.","family":"Nambiar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Esparza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woonghee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon-Yong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen P.","family":"Olkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnaz","family":"Ghaemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falguni","family":"Basuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwamena E.","family":"Baidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Sheehan-Klenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hima","family":"Makala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei H.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M.","family":"Farber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Choyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy E.","family":"Escorcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orit","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"2026070106450736000_67.7.1164.1","doi-asserted-by":"publisher","DOI":"10.3322\/CAAC.21834"},{"key":"2026070106450736000_67.7.1164.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0186-y"},{"key":"2026070106450736000_67.7.1164.3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","article-title":"Hepatocellular carcinoma: signaling pathways and therapeutic advances","volume":"10","author":"Zheng","year":"2025","journal-title":"Signal Transduct Target Ther."},{"key":"2026070106450736000_67.7.1164.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1713263"},{"key":"2026070106450736000_67.7.1164.5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/PPO.0000000000000435","article-title":"Radiomics, radiogenomics, and next-generation molecular imaging to augment diagnosis of hepatocellular carcinoma","volume":"26","author":"Bell","year":"2020","journal-title":"Cancer J."},{"key":"2026070106450736000_67.7.1164.6","doi-asserted-by":"publisher","DOI":"10.1097\/01.cej.0000236245.40619.c3"},{"key":"2026070106450736000_67.7.1164.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2007.08.014"},{"key":"2026070106450736000_67.7.1164.8","doi-asserted-by":"crossref","first-page":"1149931","DOI":"10.3389\/fimmu.2023.1149931","article-title":"Role of CD147 in the development and diagnosis of hepatocellular carcinoma","volume":"14","author":"Huang","year":"2023","journal-title":"Front Immunol."},{"key":"2026070106450736000_67.7.1164.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2008.11.001"},{"key":"2026070106450736000_67.7.1164.10","first-page":"589","article-title":"Biological characteristics of cluster of differentiation 147 and its relationship with tumour","volume":"38","author":"Gao","year":"2016","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao."},{"key":"2026070106450736000_67.7.1164.11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S2468-1253(19)30422-4","article-title":"Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial","volume":"5","author":"Li","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"2026070106450736000_67.7.1164.12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.iotech.2020.07.001","article-title":"Nanobodies as non-invasive imaging tools","volume":"7","author":"Rashidian","year":"2020","journal-title":"Immunooncol Technol."},{"key":"2026070106450736000_67.7.1164.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.270167"},{"key":"2026070106450736000_67.7.1164.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.265171"},{"key":"2026070106450736000_67.7.1164.15","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1021\/acsmedchemlett.3c00213","article-title":"Development of iodinated indocyanine green analogs as a strategy for targeted therapy of liver cancer","volume":"14","author":"Marker","year":"2023","journal-title":"ACS Med Chem Lett."},{"key":"2026070106450736000_67.7.1164.16","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2014.039"},{"key":"2026070106450736000_67.7.1164.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79036-0"},{"key":"2026070106450736000_67.7.1164.18","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.62347\/TTNY4279","article-title":"Glypican-3 deficiency in liver cancer upregulates MAPK\/ERK pathway but decreases cell proliferation","volume":"14","author":"Chung","year":"2024","journal-title":"Am J Cancer Res."},{"key":"2026070106450736000_67.7.1164.19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1021\/acs.molpharmaceut.4c01101","article-title":"Comparative kidney uptake of nanobody-based PET tracers labeled with various fluorine-18-labeled prosthetic groups","volume":"22","author":"Olkowski","year":"2025","journal-title":"Mol Pharm."},{"key":"2026070106450736000_67.7.1164.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.269795"},{"key":"2026070106450736000_67.7.1164.21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky092"},{"key":"2026070106450736000_67.7.1164.22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.14701\/ahbps.2017.21.4.194","article-title":"Clinical usefulness of FDG-PET in patients with hepatocellular carcinoma undergoing surgical resection","volume":"21","author":"Cho","year":"2017","journal-title":"Ann Hepatobiliary Pancreat Surg."},{"key":"2026070106450736000_67.7.1164.23","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s00259-024-06985-3","article-title":"Radioiodinated nanobody immunoPET probe for in\u00a0vivo detection of CD147 in pan-cancer","volume":"52","author":"Ma","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026070106450736000_67.7.1164.24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41401-023-01162-y","article-title":"124I-labeled anti-CD147 antibody for noninvasive detection of CD147-positive pan-cancers: construction and preclinical studies","volume":"45","author":"Ma","year":"2024","journal-title":"Acta Pharmacol Sin."},{"key":"2026070106450736000_67.7.1164.25","doi-asserted-by":"crossref","first-page":"704309","DOI":"10.3389\/fimmu.2021.704309","article-title":"Differential CD147 functional epitopes on distinct leukocyte subsets","volume":"12","author":"Pata","year":"2021","journal-title":"Front Immunol."},{"key":"2026070106450736000_67.7.1164.26","doi-asserted-by":"crossref","first-page":"e00283","DOI":"10.1042\/BSR20150256","article-title":"How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity","volume":"36","author":"Grass","year":"2015","journal-title":"Biosci Rep."},{"key":"2026070106450736000_67.7.1164.27","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4161\/cbt.5.3.2431","article-title":"Biodistribution and localization of iodine-131-labeled metuximab in patients with hepatocellular carcinoma","volume":"5","author":"Zhang","year":"2006","journal-title":"Cancer Biol Ther."},{"key":"2026070106450736000_67.7.1164.28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13550-018-0374-8","article-title":"I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma","volume":"8","author":"Carrasquillo","year":"2018","journal-title":"EJNMMI Res."},{"key":"2026070106450736000_67.7.1164.29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1158\/1078-0432.CCR-25-1856","article-title":"Glypican-3-targeted PET imaging for precise diagnosis of hepatocellular carcinoma: from bench to bedside","volume":"32","author":"Lin","year":"2026","journal-title":"Clin Cancer Res."},{"key":"2026070106450736000_67.7.1164.30","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266766"},{"key":"2026070106450736000_67.7.1164.31","doi-asserted-by":"publisher","DOI":"10.7150\/thno.8156"},{"key":"2026070106450736000_67.7.1164.32","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.3390\/cancers15133493","article-title":"Targeted alpha therapy (TAT) with single-domain antibodies (nanobodies)","volume":"15","author":"Hurley","year":"2023","journal-title":"Cancers (Basel)."},{"key":"2026070106450736000_67.7.1164.33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nucmedbio.2017.09.003","article-title":"Astatine-211 labeled anti-HER2 5F7 single domain antibody fragment conjugates: radiolabeling and preliminary evaluation","volume":"56","author":"Choi","year":"2018","journal-title":"Nucl Med Biol."},{"key":"2026070106450736000_67.7.1164.34","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1021\/acs.molpharmaceut.9b00354","article-title":"Labeling of anti-HER2 nanobodies with astatine-211: optimization and the effect of different coupling reagents on their in\u00a0vivo behavior","volume":"16","author":"Dekempeneer","year":"2019","journal-title":"Mol Pharm."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.271565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:05:49Z","timestamp":1782914749000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.271565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,1]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.2967\/jnumed.125.271565"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.271565","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]}}}